Related Experiment Video
Updated: Dec 24, 2025
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Quantum dots tethered membrane type 3 matrix metalloproteinase-targeting peptide for tumor optical imaging
1College of Food Science and Engineering, Jilin University, 5333 Xi'an Street, Changchun, Jilin 130062, P. R. China.
Abstract:
Membrane type matrix metalloproteinases (MT-MMPs) play important roles in malignant tumor progression through the degradation of the extracellular matrix and signal transduction. However, a member of the family, MT3-MMP, has attracted the least concern compared with other MT-MMPs. Here, a novel MT3-MMP-targeting peptide with high affinity and specificity has been developed by a phage-display peptide screening technology and multiple biophysics measurements, including single-molecule recognition force spectroscopy and isothermal titration calorimetry. The binding peptides are conjugated on the surface of CdSe/ZnS quantum dots (QDs) and consequently acted as a ligand that specifically targets MT3-MMP overexpressed tumor cells. The imaging nanoprobes used QDs as the photographic developer for optical imaging in vivo. The nanoprobes exhibited a desirable targeting effect and generated good biodistribution profiles for visualization and imaging of MT3-MMP overexpressed tumor. The peptide could be useful to evaluate the distribution and expression of MT3-MMP. Furthermore, the peptide-functionalized QDs show potential application for cancer diagnosis.
Insights
Researchers developed a novel peptide targeting MT3-MMP, a protein implicated in cancer. This peptide, conjugated to quantum dots, enables specific imaging of MT3-MMP-overexpressing tumors for potential cancer diagnosis.
Area of Science:
- Biochemistry
- Nanotechnology
- Oncology
Background:
- Membrane type matrix metalloproteinases (MT-MMPs) are crucial in tumor progression via extracellular matrix degradation and signal transduction.
- MT3-MMP, a specific MT-MMP, is less studied but plays a role in malignant tumors.
- Targeting MT3-MMP offers a potential strategy for cancer diagnosis and therapy.
Purpose of the Study:
- To develop a novel peptide with high affinity and specificity for MT3-MMP.
- To create MT3-MMP-targeting nanoprobes for in vivo optical imaging.
- To evaluate the potential of these nanoprobes for cancer diagnosis.
Main Methods:
- Phage-display peptide screening technology was employed to identify MT3-MMP-binding peptides.
- Biophysical techniques, including single-molecule recognition force spectroscopy and isothermal titration calorimetry, were used for validation.
- CdSe/ZnS quantum dots (QDs) were conjugated with the identified peptides to form imaging nanoprobes.
Main Results:
- A novel peptide with high affinity and specificity for MT3-MMP was successfully developed.
- The peptide-functionalized QDs demonstrated specific targeting of MT3-MMP-overexpressing tumor cells.
- In vivo optical imaging revealed desirable biodistribution profiles for tumor visualization.
Conclusions:
- The developed peptide is effective for evaluating MT3-MMP distribution and expression.
- Peptide-functionalized QDs show significant potential as imaging nanoprobes for MT3-MMP-overexpressing tumors.
- This approach holds promise for advancing cancer diagnosis.
More Related Videos
06:46Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
Published on: May 8, 2017
09:00Long-term Intravital Immunofluorescence Imaging of Tissue Matrix Components with Epifluorescence and Two-photon Microscopy
Published on: April 22, 2014